Treatment Decision Making in Relapsed/Refractory Multiple Myeloma
To address the complexities of relapsed/refractory multiple myeloma, a panel of experts reviews a clinical case and delivers a roadmap for potential treatment options.
EP. 1: Case Study: 63-Year-Old Man With Multiple Myeloma
A team of multiple myeloma experts review a patient profile, offering preliminary insights and underscoring the importance of advanced practice providers in optimizing patient care.
EP. 2: Empowering Patients With Myeloma Through Resources
The panel discussed resources to equip nurses in educating patients with multiple myeloma about their treatment options.
EP. 3: Clinical Scenario: Treating Late-Line Relapsed Multiple Myeloma
Following the repeat diagnostic workup presentation, an expert will lead the discussion, inviting the panel's input on the most appropriate treatment course for this patient.
EP. 4: Navigating MM Treatment: Sequencing Strategies and Integrating Talquetamab
This session explores clinical evidence for sequencing treatments in MM, highlighting the safety profile of talquetamab as a potential tool in your MM patient management.
EP. 5: Strategies for Discussing Potential Adverse Effects of Talquetamab in MM
Experts discuss best practices for educating patients with multiple myeloma on the adverse effects associated with talquetamab treatment.
EP. 6: Managing Toxicities From Talquetamab in Multiple Myeloma
Experts explore strategies to effectively manage toxicities associated with talquetamab in the treatment of multiple myeloma.
EP. 7: Integrating GPRC5D-Targeting Bispecifics for Relapsed/Refractory MM
Beth Faiman, PhD, MSN, explores how a GPRC5D-targeting bispecific antibody can benefit patients with relapsed/refractory multiple myeloma.
EP. 8: Clinical Advice on Caring for Patients Treated With Talquetamab
The panel provides clinical advice on caring for patients with multiple myeloma who are treated with talquetamab.
EP. 9: Insights on Evolving Treatment Strategies for Multiple Myeloma
The panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.
